Literature DB >> 11150858

Increased apoptosis in acute puromycin aminonucleoside nephrosis.

L Fernandez1, M Romero, H Soto, J Mosquera.   

Abstract

Acute puromycin aminonucleoside nephrosis (PAN) in rats is characterized by heavy proteinuria associated with renal hypercellularity. The role of apoptosis in the resolution of renal hypercellularity was investigated in PAN. To study the participation of apoptosis in PAN, renal tissues were collected from nephrotic and control rats on weeks 1, 2 and 7 after a single puromycin aminonucleoside injection. Apoptosis was evaluated by light and electron microscopy. Apoptotic DNA fragmentation was detected by TUNEL staining. Renal tissues were also evaluated by the presence of leukocyte common antigen (LCA), ED1 (macrophages) and proliferating cell nuclear antigen (PCNA) with corresponding monoclonal antibodies. An increased number of apoptotic (TUNEL+) cells was observed in the glomerulus at week 1. Electron microscopy analysis showed glomerular apoptosis mainly in endothelial cells. In the interstitium and tubules, increased apoptosis was observed at weeks 1 and 2. Increased apoptosis was accompanied with increased LCA+, ED1+ and PCNA+ cells in the interstitium and with increased PCNA+ cells in tubules. There was a high significant correlation between the number of apoptotic cells and the number of interstitial LCA+, ED1+ and PCNA+ cells. Tubular PCNA expression was correlated with tubular apoptosis. We also observed significant correlation between glomerular, interstitial and tubular apoptosis with proteinuria during the nephrosis. Double staining analysis showed that about 13% of interstitial or tubular apoptotic cells were positive for PCNA. All these values returned to normal by week 7. These results indicate that apoptosis is involved in the repairing process of this disease model. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150858     DOI: 10.1159/000052600

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  7 in total

1.  Podocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.

Authors:  Andrey V Cybulsky; Tomoko Takano; Joan Papillon; Julie Guillemette; Andrew M Herzenberg; Chris R J Kennedy
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

2.  CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.

Authors:  Caroline B Marshall; Ron D Krofft; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-03

3.  Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis.

Authors:  Bohan Chen; Zubia Alam; Yan Ge; Lance Dworkin; Rujun Gong
Journal:  Front Physiol       Date:  2022-06-01       Impact factor: 4.755

4.  Retinoids as a potential treatment for experimental puromycin-induced nephrosis.

Authors:  V Moreno-Manzano; F Mampaso; J C Sepúlveda-Muñoz; M Alique; S Chen; F N Ziyadeh; M C Iglesias-de la Cruz; J Rodríguez; E Nieto; J M Orellana; P Reyes; I Arribas; Q Xu; M Kitamura; F J Lucio Cazana
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

5.  Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.

Authors:  Yumin Wen; Yongli Zhan; Huijie Liu; Tingting Zhao; Liping Yang; Haojun Zhang; Xi Dong; Ping Li
Journal:  BMC Complement Altern Med       Date:  2015-05-27       Impact factor: 3.659

6.  Plantago asiatica L. Ameliorates Puromycin Aminonucleoside-Induced Nephrotic Syndrome by Suppressing Inflammation and Apoptosis.

Authors:  Min Chul Kho; Ji Hun Park; Byung Hyuk Han; Rui Tan; Jung Joo Yoon; Hye Yoom Kim; You Mee Ahn; Yun Jung Lee; Dae Gill Kang; Ho Sub Lee
Journal:  Nutrients       Date:  2017-04-14       Impact factor: 5.717

7.  Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria.

Authors:  Erika B Rangel; Samirah A Gomes; Rosemeire Kanashiro-Takeuchi; Russell G Saltzman; Changli Wei; Phillip Ruiz; Jochen Reiser; Joshua M Hare
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.